The Hindu Editorial Analysis: 12th Sep 2022

The Hindu Editorial Analysis:

We all are aware of the importance of reading The Hindu newspaper with the aspect of improving reading ability, easily comprehending paragraphs, getting updated with the current events, improving essay writing and many more. For a banking aspirant it becomes necessary to read editorials for vocabulary. In this article we are going to discuss the points of today’s editorials with practice questions and important vocabs.

In today’s article we are going to analyse the editorial about India’s first nasal COVID vaccine and its impact on the struggle against COVID.

Nasal COVID vaccine:

  • India’s first Nasal COVID vaccine can help in giving speed to mass immunization across the country. It should give stimulus to India’s ambition to completely eliminate COVID from the country.
  • A Nasal vaccine is that vaccine which is administered by the nose. It doesn’t need any needle to administer it to the human body.
  • The COVID pandemic has forced health industries, science and technologies to take initiatives and innovative development to find various solutions for eradicating coronavirus from the world.
  • India has done a great job in manufacturing and providing vaccines across the world.
  • Many COVID vaccines have come into the markets and have given security to combat coronavirus from spreading, reduced the burden of hospitals and prevented transmissions.
  • But only the nasal COVID vaccine gives the hope of its promise to prevent further transmission by restricting the entry of the virus into the body.
  • This quality of the nasal vaccine gives it the right to have emergency use authorization for primary immunization to those people who are 18 or above and it is a welcoming step.
  • Another quality of the nasal vaccine that makes it more preferable is that it doesn’t need any needle so that people especially children can now have painless immunisation without needle.
  • The theory of the nasal vaccine describes that the nasal vaccine ensures to stop the virus from binding with the host cell at the very first time of entry of the virus.
  • But there is no proper evidence of that theory.
  • There are other nasal vaccines which have been approved for use across the world but they have very little data.
  • The Bharat Biotech which is the producer of the nasal COVID vaccine of India, had conducted 3 trials before getting authorization for use as primary immunization.
  • The company has promised that it would publish the data of those trials in the public.
  • Even though the number of cases are now decreasing, the immunization of those people who have been left is still the top priority.
  • The government and responsible health industries should become more transparent about the data of trials and vaccines.

SBI Clerk Notification 2022 – 5800 total Vacancies

Practice questions:

  • What is a nasal vaccine? How can it become the first priority to immunize people against COVID?
  • What are the qualities of India’s first nasal COVID vaccine?
  • Give a brief description about India’s first nasal COVID vaccine.

Important vocab:

Incremental: relating to an increase 

Retard: delay the development 

Virtue: high moral standards 

Trypanophobia: extreme fear of needles 

Emphasising: give special importance to

Battling: struggle to achieve something 

Punctuated: occurs at intervals

Click to Buy Bank MahaCombo Package

Download Online Mock Test Mobile APP



Leave a Reply